½ÃÀ庸°í¼­
»óǰÄÚµå
1589017

¼¼°èÀÇ ¾È±¸ º¸Ã¶¹° ½ÃÀå

Ocular Prosthesis

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 93 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾È±¸ º¸Ã¶¹° ¼¼°è ½ÃÀå, 2030³â±îÁö 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 15¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾È±¸ º¸Ã¶¹° ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.5% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º´¿ø ÃÖÁ¾ »ç¿ë ºÎ¹®Àº CAGR 6.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 13¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¸®´Ð ÃÖÁ¾ »ç¿ë ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È CAGR 5.9%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ ½ÃÀå 3¾ï 8,370¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¹Ì±¹ÀÇ ¾È±¸ º¸Ã¶¹° ½ÃÀåÀº 2023³â 3¾ï 8,370¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 5¾ï 5,060¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 10.0%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.8%¿Í 5.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 4.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¾È±¸ º¸Ã¶¹° ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¾È±¸ º¸Ã¶¹°À̶õ ¹«¾ùÀΰ¡?

¾È±¸ º¸Ã¶¹°Àº ÀϹÝÀûÀ¸·Î ÀǾÈ(ëùäÑ)À̶ó°í ºÒ¸®¸ç, °á¼Õ ¶Ç´Â ¼Õ»óµÈ ¾È±¸¸¦ ´ëüÇϵµ·Ï ¼³°èµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ºÎ»ó, Áúº´, ¼±Ãµ¼º ÁúȯÀ¸·Î ÀÎÇØ ¾È±¸¸¦ ÀÒÀº ȯÀÚ¸¦ À§ÇØ ¸ÂÃã Á¦À۵˴ϴÙ. ¾È±¸ º¸Ã¶¹°ÀÇ ÀÏÂ÷ÀûÀÎ ¸ñÀûÀº ȯÀÚÀÇ ¹ÌÀû ¿Ü°üÀ» ȸº¹ÇÏ´Â °ÍÀÌÁö¸¸, ½Ã·ÂÀ» ȸº¹ÇÏ´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ¾È±¸ º¸Ã¶¹° »ç¿ëÀÇ ½É¸®Àû, Á¤¼­Àû ÀÌÁ¡Àº ¸Å¿ì Ä¿¼­ ÀÏ»ó »ýȰ¿¡¼­ Àڽۨ°ú Æò¿ÂÇÔÀ» µÇã´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀǾÈÀº ÀÚ¿¬ ¾È±¸ÀÇ »ö°ú ¸ð¾ç¿¡ ÃÖ´ëÇÑ °¡±õ°Ô Á¦ÀÛµÇ¾î ´ëºÎºÐÀÇ °æ¿ì ½ÇÁ¦ ¾È±¸¿Í ±¸º°ÇÒ ¼ö ¾øÀ» Á¤µµ·Î ºñ½ÁÇÏ°Ô ¸¸µé¾îÁý´Ï´Ù.

¾È±¸ º¸Ã¶¹° Á¦Á¶ °øÁ¤Àº ¼¼½ÉÇÑ ÁÖÀǸ¦ ±â¿ï¿© °íµµ·Î ¸ÂÃãÈ­µÇ¾î ÀÖ½À´Ï´Ù. º¸Ã¶¹°ÀÌ ¿Ïº®ÇÏ°í Æí¾ÈÇÏ°Ô ¸ÂÀ» ¼ö ÀÖµµ·Ï ȯÀÚÀÇ ¾È¿Í¸¦ ÀÚ¼¼È÷ »ó´ãÇϰí ÃøÁ¤ÇÏ´Â °ÍºÎÅÍ ½ÃÀ۵˴ϴÙ. µðÁöÅÐ ½ºÄ³´×°ú °°Àº ÷´Ü ¿µ»ó ±â¼úÀº Á¾Á¾ ¾È¿ÍÀÇ Á¤È®ÇÑ µðÅ×ÀÏÀ» Æ÷ÂøÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. ÃøÁ¤ÀÌ ³¡³ª¸é, º¸Ã¶¹°Àº ÀϹÝÀûÀ¸·Î ³»±¸¼º°ú »ýüÀûÇÕ¼ºÀÌ ¶Ù¾î³­ ÀÇ·á¿ë ¾ÆÅ©¸±·Î Á¦À۵˴ϴÙ. ±ÝÇüÀ» ¸¸µé°í ¾ÆÅ©¸±À» ¼ºÇü, µµÀå, ¿¬¸¶ÇÏ¿© ȯÀÚÀÇ ÀÚ¿¬½º·¯¿î ´« ¸ð¾çÀ» Á¤È®ÇÏ°Ô ¸ð¹æÇÕ´Ï´Ù. ÃֽŠÁ¦Á¶ ±â¼úÀº °ø¸·ÀÇ Á¤¸Æ¿¡¼­ ȫäÀÇ Á¤È®ÇÑ »öÁ¶±îÁö ¸ðµç ¼¼ºÎ »çÇ×À» Á¤±³ÇÏ°Ô ÀçÇöÇÏ¿© º¸Ã¶¹°ÀÌ °¡´ÉÇÑ ÇÑ »ç½ÇÀûÀ¸·Î º¸À̵µ·Ï ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÃÖ±Ù Àç·á¿Í 3D ÇÁ¸°ÆÃ ±â¼úÀÇ ¹ßÀüÀº Àΰø¼öÁ¤Ã¼ Á¦Á¶¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Á¦Á¶ ½Ã°£À» ´ÜÃàÇÏ°í ´õ¿í Á¤¹ÐÇÑ ¸ÂÃã Á¦ÀÛÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº º¸´Ù È¿À²ÀûÀ̰í Àú·ÅÇÑ ºñ¿ëÀ¸·Î Àΰø¼öÁ¤Ã¼¸¦ Á¦Á¶ÇÒ ¼ö ÀÖ°Ô ÇÏ¿© Àΰø¼öÁ¤Ã¼ÀÇ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýüÀûÇÕ¼º ¼ÒÀçÀÇ °³¼±À¸·Î ÀǾÈÀÇ Æí¾ÈÇÔ°ú ³»±¸¼ºÀÌ Çâ»óµÇ¾î Âø¿ëÀÚÀÇ Àڱذú °¨¿° À§ÇèÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. Àΰø ¾È±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°è ȯÀÚµéÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇÑ ±â¼ú Çõ½ÅÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.

¾È±¸ º¸Ã¶¹°ÀÇ ÁÖ¿ä ¿ëµµ¿Í ÀåÁ¡Àº ¹«¾ùÀΰ¡?

Àΰø¼öÁ¤Ã¼´Â ÁÖ·Î ¹Ì¿ë±â±¸ÀÇ ¿ªÇÒÀ» ÇÏÁö¸¸, ±× ¿µÇâÀº ¿Ü¸ð¿¡¸¸ ±¹ÇѵÇÁö ¾Ê½À´Ï´Ù. ¿Ü»ó, ¼ö¼ú, Áúº´ µîÀ¸·Î ´«À» ÀÒÀº »ç¶÷µé¿¡°Ô ¾È±¸ º¸Ã¶¹°À» Âø¿ëÇÏ¸é ½É¸®Àû, Á¤¼­Àû ÀÌÁ¡ÀÌ ¸Å¿ì Å®´Ï´Ù. ÀÚ¿¬½º·¯¿î ¿Ü¸ðÀÇ È¸º¹Àº ¾È±¸ ¼Õ½Ç·Î ÀÎÇÑ »çȸÀû ³«ÀÎÀ» ¿ÏÈ­Çϰí, ȯÀÚ´Â »çȸÀû, Á÷¾÷Àû, °³ÀÎÀû ±³·ù¿¡ ÀڽۨÀ» °¡Áö°í Âü¿©ÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù. ÀÌ·¯ÇÑ ÀÚÁ¸°¨ Çâ»óÀº ¾È±¸ º¸Ã¶¹° ½Ã¼úÀÇ °¡Àå Á÷Á¢ÀûÀÎ ÀÌÁ¡ Áß Çϳª·Î Á¾Á¾ º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾È¿Í¿Í ÁÖº¯ ±¸Á¶¹°ÀÇ ¸ð¾çÀ» À¯ÁöÇÏ°í ¾È±¸ ÀûÃâ ÈÄ ¹ß»ýÇÒ ¼ö ÀÖ´Â ºØ±«¿Í ¼öÃàÀ» ¹æÁöÇÏ´Â µî ±â´ÉÀûÀÎ ÀÌÁ¡µµ ÀÖ½À´Ï´Ù.

Á¤½ÅÀû, ½É¸®Àû Áö¿ø ¿Ü¿¡µµ ¾È¿Í º¸Ã¶Àº ¾È¿ÍÀÇ ¼¶¼¼ÇÑ Á¶Á÷À» º¸È£ÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¾È±¸¸¦ Á¦°ÅÇÑ ÈÄ ¾È¿Í°¡ Àڱذú °¨¿°ÀÇ ¿µÇâÀ» ¹Þ±â ½±½À´Ï´Ù. ÀǾÈÀº º¸È£ À庮 ¿ªÇÒÀ» ÇÏ¿© ¸ÕÁö, ¾²·¹±â, °¨¿°À» À¯¹ßÇÏ´Â ¼¼±Õ°ú °°Àº ȯ°æÀû ¿ä¼Ò·ÎºÎÅÍ ³ëÃâµÈ Á¶Á÷À» º¸È£ÇÕ´Ï´Ù. ¶ÇÇÑ ¼Õ»óµÈ ¾È±¸ÀÇ ±â´ÉÀÌ ÀϺΠ³²¾ÆÀÖ´Â °æ¿ì Ư¼ö Àΰø¼öÁ¤Ã¼¸¦ ¼³°èÇÏ¿© ±â´ÉÀû ½Ã·Â º¸Á¶ ÀåÄ¡¿Í ÇÔ²² »ç¿ëÇÏ¿© Àü¹ÝÀûÀÎ ½Ã°¢Àû °æÇèÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

Àΰø¼öÁ¤Ã¼´Â ¶ÇÇÑ º¸´Ù Á¾ÇÕÀûÀÎ Ä¡·á Á¢±Ù¹ýÀ» Á¦°øÇϱâ À§ÇØ Ã·´Ü ¼ö¼ú ±â¼ú°ú ÇÔ²² »ç¿ëµÇ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¾È±¸ÀÇ Àüü ¶Ç´Â ÀϺθ¦ Á¦°ÅÇÏ´Â ¾È±¸ ÀûÃâ¼úÀ̳ª ¾È±¸ ÀûÃâ¼ú ÈÄ ¾ó±¼ÀÇ ´ëĪÀ» ȸº¹Çϱâ À§ÇØ ÀǾÈÀ» Âø¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀǾÈÀº ¹Ì¿ë È¿°ú¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ÀçȰ °úÁ¤¿¡µµ µµ¿òÀÌ µÇ¾î ȯÀÚ°¡ ´Ü¾È »ýȰ¿¡ ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Àç·á¿Í ±â¼úÀÇ Çõ½ÅÀ¸·Î ÀǾÈÀº Á¡Á¡ ´õ Æí¾ÈÇÏ°í ³»±¸¼ºÀÌ ¶Ù¾î³ª°í Çö½ÇÀûÀ̵Ǿî ȯÀÚ°¡ ¿Ü¸ð¿Í ÀÏ»ó »ýȰ¿¡¼­ Á¤»óÀûÀÎ °¨°¢À» ȸº¹ ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

¾È±¸ º¸Ã¶¹°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Àΰø¾È ¼ö¿ä´Â ÀÇ·á ±â¼úÀÇ ¹ßÀü, ÀνÄÀÇ Çâ»ó, ´«°ú °ü·ÃµÈ ºÎ»ó ¹× Áúº´ÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀ¸·Î ÀÎÇØ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÇÙÁ¦°Å¼ú ¹× ¾È±¸ ÀûÃâ¼ú°ú °°Àº ¾È±¸ ÀûÃâ ¼ö¼ú ±â¼úÀÇ Çâ»óÀÔ´Ï´Ù. ½É°¢ÇÑ ¾È±¸ ¿Ü»óÀ̳ª ¸Á¸·¸ð¼¼Æ÷Á¾, ³ì³»Àå µîÀÇ ÁúȯÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô ÁÖ·Î ÇÊ¿äÇÑ ÀÌ·¯ÇÑ ¼ö¼úÀº ÀÌÁ¦ ´õ ÀÚÁÖ ½ÃÇàµÇ°í ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó °íǰÁú ¸ÂÃãÇü ÀǾȿ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÷´Ü À̹ÌÁö ó¸® ±â¼ú°ú 3D ÇÁ¸°ÆÃ ±â¼úÀÌ ÀÇ¾È Á¦Á¶¿¡ ÅëÇյǸ鼭 º¸´Ù ºü¸£°í Á¤È®ÇÑ Á¦Á¶ °øÁ¤ÀÌ °¡´ÉÇØÁ³°í, ȯÀÚµéÀº ´õ ªÀº ½Ã°£ ³»¿¡ ´õ Àß ¸Â°í ¹ÌÇÐÀûÀ¸·Î ¿ì¼öÇÑ ÀǾÈÀ» ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¼ö¿ä Áõ°¡ÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ÀÇ¾È Âø¿ëÀÇ ½É¸®Àû ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ´õ ¸¹Àº ȯÀÚµéÀÌ ÀÇ¾È ¿É¼Ç¿¡ ´ëÇØ ¾Ë°Ô µÇ¸é¼­ äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Ç¸í¿¡ ´ëÇÑ »çȸÀû ³«ÀÎÀÌ »ç¶óÁö°í ÀÖÀ¸¸ç, °³ÀÎÀº ½É¹ÌÀûÀÎ ÀÌÀ¯»Ó¸¸ ¾Æ´Ï¶ó Àڽۨ°ú »çȸÀû ±³·ù¸¦ Çâ»ó½Ã۱â À§ÇØ ÀÇ¾È Âø¿ëÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »çȸÀû ÀνÄÀÇ º¯È­´Â ´õ ¸¹Àº »ç¶÷µéÀÌ ±³Á¤ ¼ö¼úÀ» ¹ÞÀº ÈÄ ÀǾÈÀ» Âø¿ëÇϵµ·Ï À¯µµÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¶ÇÇÑ Àα¸ÀÇ °í·ÉÈ­´Â ÀÇ¾È ¼ö¿ä Áõ°¡¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ³ì³»Àå, Ȳ¹Ýº¯¼º, ´ç´¢¸Á¸·º´Áõ°ú °°Àº ³ëÈ­ °ü·Ã ¾ÈÁúȯÀº ½Ã·ÂÀÇ ÀϺΠ¶Ç´Â ÀüºÎ¸¦ ÀÒ°Ô ÇÏ°í ¶§·Î´Â ¾È±¸ ÀûÃâÀÌ ÇÊ¿äÇÒ ¼öµµ ÀÖ½À´Ï´Ù. Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀǾÈÀ» ÇÊ¿ä·Î Çϴ ȯÀÚ ¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû Ãß¼¼¿Í ¾È°ú ¹× ÀÇ¾È ºÐ¾ßÀÇ ¹ßÀüÀº ¾È°ú ¹× ÀÇ¾È ºÐ¾ßÀÇ ¹ßÀü°ú ÇÔ²² ¾È±¸ º¸Ã¶¹° ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¾È±¸ º¸Ã¶¹° ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¾È±¸ º¸Ã¶¹° ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿ì¼±, Àü ¼¼°èÀûÀ¸·Î ´«°ú °ü·ÃµÈ ¿Ü»ó ¹× Áúº´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àΰø ¾È±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾Ï(¸Á¸·¸ð¼¼Æ÷Á¾), ³ì³»Àå, ÁßÁõ °¨¿°°ú °°Àº Áúº´Àº Á¾Á¾ ¾È±¸ ÀûÃâ·Î À̾îÁö°í ȯÀÚ´Â ÀǾÈÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. »ç°í¿Í ºÎ»óÀÇ Áõ°¡, ƯÈ÷ »ê¾÷ÀçÇØ¿Í ±³Åë»ç°í°¡ ¸¹Àº Áö¿ª¿¡¼­ÀÇ ºÎ»ó Áõ°¡µµ ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÊ¿¡ µû¶ó ¼ö¼ú ÈÄ ¾È±¸ º¸Ã¶¹°À» ÇÊ¿ä·Î ÇÏ´Â ¼ö¼ú ȯÀÚ°¡ Áõ°¡Çϸ鼭 ¾È±¸ º¸Ã¶¹° ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ ÁÖ¿ä ¿øµ¿·ÂÀº ÀÇ·á ±â¼ú, ƯÈ÷ 3D ÇÁ¸°ÆÃ°ú »ýüÀûÇÕ¼º Àç·áÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÀÇ¾È ¼³°è ¹× Á¦Á¶¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ °íµµ·Î ¸ÂÃãÈ­µÇ°í ³»±¸¼ºÀÌ ¶Ù¾î³ª¸ç Æí¾ÈÇÑ ÀÇ¾È Á¦Á¶¸¦ °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ 3D ÇÁ¸°ÆÃÀº ȯÀÚÀÇ ÀÚ¿¬ ¾È±¸¸¦ Á¤È®ÇÏ°Ô ÀçÇöÇÒ ¼ö ÀÖ¾î ½Ã°¢ÀûÀ¸·Î ½ÇÁ¦ ¾È±¸¿Í ±¸º°ÇÒ ¼ö ¾ø´Â ÀǾÈÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á¿ë ¾ÆÅ©¸±, ½Ç¸®ÄÜ µî ÀÇ¾È Á¦ÀÛ¿¡ »ç¿ëµÇ´Â ¼ÒÀçÀÇ °³¼±À¸·Î ȯÀÚÀÇ Æí¾ÈÇÔÀÌ Çâ»óµÇ°í °¨¿°°ú ¿°ÁõÀÇ À§ÇèÀÌ ÁÙ¾îµé¾î äÅ÷üÀÌ ³ô¾ÆÁ³½À´Ï´Ù.

¼ÒºñÀÚÀÇ Çൿ°ú Àνĵµ ½ÃÀå ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Á¡Á¡ ´õ ¸¹Àº »ç¶÷µéÀÌ Àΰø ¾È±¸ÀÇ »ç¿ë °¡´É¼º°ú ½É¸®Àû ÀÌÁ¡À» ÀνÄÇÔ¿¡ µû¶ó ¸ÂÃãÇü ÀǾȿ¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¹Ì¿ë¿¡ Á¡Á¡ ´õ ÁýÁßÇϰí ÀÖ´Â ¹Ì¿ë »ê¾÷Àº ¼ö¼ú ÈÄ ÀçȰÀÇ ÀÏȯÀ¸·Î ÀÇ¾È »ç¿ëÀ» Á¤»óÈ­ÇÏ´Â µ¥ ÀÏÀÍÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ ¿Ü»óÀ̳ª ¼ö¼ú ÈÄ È¯ÀÚÀÇ Á¤½ÅÀû ¾È³ç¿¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̸鼭 ÀǾÈÀ» Ä¡·á °èȹ¿¡ Æ÷ÇÔ½ÃŰ´Â °ÍÀÌ º¸ÆíÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½Å, ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»ó, ¼ÒºñÀÚ ÀνÄÀÇ º¯È­´Â Àü ¼¼°è ¾È±¸ º¸Ã¶¹° ½ÃÀåÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 42°Ç)

  • Alcon
  • Bausch & Lomb
  • Carl Zeiss
  • Johnson & Johnson
  • Morcher GmbH
  • Staarr surgical

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

ksm 24.11.18

Global Ocular Prosthesis Market to Reach US$2.3 Billion by 2030

The global market for Ocular Prosthesis estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Clinics End-Use segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$383.7 Million While China is Forecast to Grow at 10.0% CAGR

The Ocular Prosthesis market in the U.S. is estimated at US$383.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$550.6 Million by the year 2030 trailing a CAGR of 10.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Ocular Prosthesis Market - Key Trends & Drivers Summarized

What Is Ocular Prosthesis and How Is It Manufactured?

An ocular prosthesis, commonly referred to as an artificial eye, is a medical device designed to replace a missing or damaged eye. It is custom-made for patients who have lost an eye due to injury, disease, or congenital conditions. The primary goal of an ocular prosthesis is to restore the aesthetic appearance of the patient, though it does not restore vision. Despite this, the psychological and emotional benefits of using an ocular prosthesis are profound, as it helps individuals regain confidence and a sense of normalcy in their daily lives. Ocular prostheses are crafted to match the color and shape of the natural eye as closely as possible, making them appear indistinguishable from a real eye in most cases.

The manufacturing process of an ocular prosthesis is a meticulous and highly customized procedure. It begins with a detailed consultation and measurement of the patient’s eye socket to ensure the prosthesis fits perfectly and comfortably. Advanced imaging techniques, such as digital scanning, are often employed to capture precise details of the socket. Once the measurements are taken, the prosthesis is typically made from medical-grade acrylic, a durable and biocompatible material. A mold is created, and the acrylic is shaped, painted, and polished to mimic the exact appearance of the patient’s natural eye. Modern manufacturing techniques allow for intricate detailing, from the veins in the sclera to the precise shade of the iris, ensuring the prosthesis looks as realistic as possible.

Recent advancements in materials and 3D printing technology have revolutionized the production of ocular prostheses, allowing for faster production times and even more precise customization. These developments have contributed to the growing accessibility of ocular prostheses, as they can now be produced more efficiently and at a lower cost. Additionally, improvements in biocompatible materials have enhanced the comfort and durability of the prosthesis, reducing the risk of irritation and infection for the wearer. As the demand for ocular prostheses continues to rise, the industry is witnessing a surge in innovation aimed at improving the quality of life for patients worldwide.

What Are the Primary Uses and Benefits of Ocular Prosthesis?

Ocular prostheses serve primarily as cosmetic devices, but their impact extends far beyond appearance. For individuals who have lost an eye due to trauma, surgery, or disease, the psychological and emotional benefits of wearing an ocular prosthesis are significant. The restoration of a natural appearance helps reduce the social stigma associated with eye loss, enabling patients to engage more confidently in social, professional, and personal interactions. This boost in self-esteem is often reported as one of the most immediate benefits of receiving an ocular prosthesis. It also offers functional advantages, such as maintaining the shape of the eye socket and surrounding structures, preventing the collapse or shrinkage that can occur after eye removal.

In addition to the emotional and psychological support, ocular prostheses play a crucial role in protecting the sensitive tissues of the eye socket. After an eye is removed, the socket is vulnerable to irritation and infection. The prosthesis acts as a protective barrier, shielding the exposed tissue from environmental elements such as dust, debris, and infection-causing bacteria. Furthermore, for those who still have partial function in the damaged eye, specialized ocular prostheses can be designed to work alongside functional vision aids, enhancing the overall visual experience.

Ocular prostheses are also increasingly being used in conjunction with advanced surgical techniques to offer a more holistic treatment approach. For instance, enucleation and evisceration surgeries, which involve the removal of all or part of the eye, are often followed by the fitting of a prosthesis to restore facial symmetry. The prosthetic eye not only enhances cosmetic results but also aids in the rehabilitation process, helping the patient adjust to life with monocular vision. With innovations in materials and technology, ocular prostheses are becoming more comfortable, durable, and realistic, allowing patients to regain a sense of normalcy in their appearance and daily activities.

Why Is Consumer Demand for Ocular Prosthesis Growing?

The demand for ocular prostheses is growing steadily, driven by several factors, including advances in medical technology, increased awareness, and a rising prevalence of eye-related injuries and diseases. One of the key factors fueling this demand is the improvement in surgical techniques for eye removal, such as enucleation and evisceration. These surgeries, which are often necessary for patients with severe eye trauma or conditions like retinoblastoma or glaucoma, are now being performed more frequently, creating a greater need for high-quality, custom-made prosthetic eyes. The integration of advanced imaging and 3D printing technologies in the manufacturing of ocular prostheses has allowed for quicker, more accurate production processes, ensuring that patients receive well-fitting, aesthetically pleasing prosthetic eyes in less time.

Another significant factor contributing to the rise in demand is the growing awareness of the psychological benefits of wearing an ocular prosthesis. More patients are becoming informed about the options available for prosthetic eyes, leading to increased adoption rates. The social stigma surrounding eye loss is diminishing, and individuals are seeking out prostheses not only for aesthetic reasons but also to boost their self-confidence and social interactions. This shift in societal perception has also encouraged more people to pursue corrective surgery followed by prosthesis fitting, further driving market demand.

Additionally, the aging population is playing a crucial role in the increased need for ocular prostheses. Age-related eye diseases such as glaucoma, macular degeneration, and diabetic retinopathy can lead to partial or total vision loss, sometimes necessitating eye removal. As global populations continue to age, the prevalence of these conditions is expected to rise, leading to an uptick in the number of patients requiring prosthetic eyes. This demographic trend, combined with advancements in the field of ophthalmology and ocular prosthetics, is significantly driving the growth of the ocular prosthesis market.

What Factors Are Driving the Growth of the Ocular Prosthesis Market?

The growth in the ocular prosthesis market is driven by several factors. First and foremost, the increasing incidence of eye-related trauma and diseases globally has led to a higher demand for ocular prostheses. Conditions such as cancer (retinoblastoma), glaucoma, and severe infections often result in eye removal, leaving patients in need of prosthetic eyes. The rise in accidents and injuries, particularly in regions with high rates of industrial and vehicular accidents, also contributes to this growing need. As the global healthcare infrastructure improves, more patients are undergoing surgical procedures that require post-surgery prosthetic fittings, thereby expanding the ocular prosthesis market.

Another key driver is the rapid advancement in medical technology, particularly in 3D printing and biocompatible materials. These technologies have revolutionized the design and manufacturing of ocular prostheses, enabling the production of highly customized, durable, and comfortable prosthetic eyes. 3D printing, in particular, allows for precise replication of the patient’s natural eye, providing a prosthesis that is visually indistinguishable from a real eye. Additionally, improvements in the materials used to create prostheses, such as medical-grade acrylic and silicone, have enhanced patient comfort and reduced the risk of infection or irritation, contributing to higher adoption rates.

Consumer behavior and awareness also play a significant role in the market’s growth. As more individuals become aware of the availability of ocular prostheses and their psychological benefits, the demand for custom-made prosthetic eyes continues to increase. The cosmetic industry, which is increasingly focusing on medical aesthetics, has played a part in normalizing the use of prostheses as part of post-surgical rehabilitation. Furthermore, as healthcare providers place a greater emphasis on the emotional well-being of patients following traumatic injury or surgery, the integration of ocular prostheses into treatment plans is becoming more widespread. This convergence of technological innovation, improved healthcare access, and changing consumer attitudes is fueling the rapid growth of the ocular prosthesis market across the globe.

Select Competitors (Total 42 Featured) -

  • Alcon
  • Bausch & Lomb
  • Carl Zeiss
  • Johnson & Johnson
  • Morcher GmbH
  • Staarr surgical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Ocular Prosthesis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Population Expands Addressable Market for Ocular Prosthesis
    • Rising Incidence of Eye Injuries Spurs Demand for Ocular Prosthesis
    • Advances in 3D Printing Technology Propel Growth in Custom Ocular Prosthesis
    • Increasing Awareness About Eye Care and Rehabilitation Bodes Well for Market Growth
    • Surge in Healthcare Spending on Reconstructive Surgeries Bodes Well for Growth
    • Advancements in Biocompatible Materials Strengthen Business Case for Ocular Prosthetics
    • Increasing Availability of Insurance Coverage Sets the Stage for Market Growth
    • Rising Medical Tourism for Eye Surgeries Generates Opportunities in Emerging Markets
    • Surge in Custom Ocular Implants Due to Cosmetic Preferences Crucial for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Ocular Prosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Ocular Prosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Ocular Prosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Specialty Eye Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Specialty Eye Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Specialty Eye Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Ocular Prosthesis Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Ocular Prosthesis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Ocular Prosthesis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Ocular Prosthesis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Ocular Prosthesis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Ocular Prosthesis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Ocular Prosthesis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • INDIA
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Ocular Prosthesis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Ocular Prosthesis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Ocular Prosthesis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Ocular Prosthesis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Ocular Prosthesis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Ocular Prosthesis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030
  • AFRICA
    • Ocular Prosthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Ocular Prosthesis by End-Use - Hospitals, Clinics and Specialty Eye Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Ocular Prosthesis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Specialty Eye Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦